Using FAPI scan to diagnose single bone lesions
Part of Bones, joints & muscles clinical trials.
This study uses a special scan (99mTc-FAPI SPECT/CT) to help tell whether a single bone spot is harmless or cancerous. It may give a clearer answer without needing a biopsy right away.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have one bone lesion that needs diagnosis (not spread to many places).
- The bone lesion can be benign (like a non-cancerous growth) or malignant (cancerous).
- You cannot be pregnant or breastfeeding.
- You must not have severe liver or kidney problems.
- You must be able to lie still for the scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study adds extra measurements during a bone scan to better understand a single unclear spot seen on standard imaging. The goal is to help doctors decide whether a biopsy (sample) or removal is needed, possibly reducing uncertainty.
This study uses a detailed bone scan (SPECT/CT) to better understand what is causing bone problems, such as cancer spread or arthritis. It helps doctors tell the difference between these two causes for better treatment.
This study uses a special type of PET scan called FAPI PET to see if it can help detect or monitor cancer and other diseases. It is for people who already need a PET or CT/MRI scan as part of their standard care.
This study tests a new type of PET scan that uses a special tracer called FAPI to find where cancer has spread in your body. It may help doctors see hidden tumors more clearly without needing extra treatments first.
This study uses a special PET scan called 18F-FAPI-04 to take detailed images of different kinds of cancer. It aims to see if this scan can help doctors better find and monitor tumors.
This trial uses a special PET scan tracer to see if it can help find and monitor diseases linked to a protein called FAP. It is for both cancer patients needing a biopsy and healthy volunteers.
Hear when a new Bone Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.